United Therapeutics reported $966.8M in Cash and Equivalent for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Amarin AMRN:US USD 240.5M 12.5M
Ardelyx ARDX:US USD 61.63M 11.2M
Baxter International BAX:US USD 1.6B 251M
Bayer BAYN:GR EUR 4.36B 949M
Biocryst Pharmaceuticals BCRX:US USD 461.19M 43.71M
Biogen BIIB:US USD 3.68B 1.03B
Biomarin Pharmaceutical BMRN:US USD 761.52M 141.71M
Emergent Biosolutions EBS:US USD 240.9M 117.2M
Esperion Therapeutics ESPR:US USD 159.4M 36.46M
Gilead Sciences GILD:US USD 6.94B 2.2B
GlaxoSmithKline GSK:LN GBP 3.61B 2.86B
Halozyme Therapeutics HALO:US USD 147.16M 56.23M
Insmed INSM:US USD 414.63M 1.44M
Intercept Pharmaceuticals ICPT:US USD 113.2M 55.18M
Intra Cellular Therapies ITCI:US USD 135.36M 58.12M
Lexicon Pharmaceuticals LXRX:US USD 18.83M 2.62M
Moderna Inc MRNA:US USD 3.03B 154M
Omeros OMER:US USD 145.53M 131.4M
Ptc Therapeutics PTCT:US USD 104.42M 53.73M
Regeneron Pharmaceuticals REGN:US USD 3.49B 96.2M
Sangamo Biosciences SGMO:US USD 94.57M 23.14M
Sarepta Therapeutics SRPT:US USD 1.04B 170.06M
Seattle Genetics SGEN:US USD 362.6M 2.27M
Teva Pharmaceutical TEVA:IT USD 2.22B 167M
United Therapeutics UTHR:US USD 966.8M 171.6M
Vertex Pharmaceuticals VRTX:US USD 9.17B 469.3M